These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22440045)

  • 1. [Benefits of subcutaneous continuous insulin infusion in type 1 diabetic patients with high glycemic variability].
    Prieto-Tenreiro A; Villar-Taibo R; Pazos-Couselo M; González-Rodríguez M; Casanueva F; García-López JM
    Endocrinol Nutr; 2012 Apr; 59(4):246-53. PubMed ID: 22440045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study.
    Giménez M; Lara M; Conget I
    Diabetes Technol Ther; 2010 Jul; 12(7):517-21. PubMed ID: 20597825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
    Catargi B; Breilh D; Roger P; Tabarin A
    Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
    Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
    Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
    Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
    Tumminia A; Crimi S; Sciacca L; Buscema M; Frittitta L; Squatrito S; Vigneri R; Tomaselli L
    Diabetes Metab Res Rev; 2015 Jan; 31(1):61-8. PubMed ID: 24816997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps.
    Catargi B; Breilh D; Gin H; Rigalleau V; Saux MC; Roger P; Tabarin A
    Diabetes Metab; 2001 Jun; 27(3):323-7. PubMed ID: 11431597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
    Wentholt IM; Maran A; Masurel N; Heine RJ; Hoekstra JB; DeVries JH
    Diabet Med; 2007 May; 24(5):527-32. PubMed ID: 17381503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
    Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
    Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
    Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes.
    Johnson SL; McEwen LN; Newton CA; Martin CL; Raskin P; Halter JB; Herman WH
    J Diabetes Complications; 2011; 25(4):211-5. PubMed ID: 21062674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.